What we do

Omixon is a global biotechnology company that commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA™ product combines a targeted HLA Assay and the Omixon HLA Twin™ software to deliver the most accurate high-resolution HLA genotyping available. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR and ABO.


Testimonials


Omixon Blog

Omixon Signs Letter of Intent with Pronto Diagnostics

At Omixon we are working hard to expand our customer base. Our Holotype HLA kit is already making an impact on the HLA typing market, and we are regularly contacted by companies proposing to partner with us as local distributors. For example, …more

By kriszta.katona 0 comments

Omixon Celebrates a Frighteningly Successful ASHI 2014 in Denver

Omixon took a team of scary mad scientists, zombie marketeers, and bloodsucking vampires (sales people) to Denver, Colorado, to the 40th Anniversary Meeting for the American Society of Histocompatibility and Immunogenetics (ASHI). Joining the team were a couple of respectable …more

By kriszta.katona 0 comments